Canine Pheochromocytoma: Diagnosis and Management

Pheochromocytoma is a rare catecholamine-secreting tumor of the adrenal medulla in dogs that requires prompt recognition, biochemical confirmation, preoperative medical stabilization, and careful surgical planning. This article provides veterinary clinicians with an evidence-based framework for diagnosing and managing this challenging condition, from initial clinical suspicion through postoperative care.

At a Glance

Pheochromocytoma arises from chromaffin cells of the adrenal medulla and secretes excessive norepinephrine and epinephrine, leading to episodic or sustained hypertension, tachycardia, and arrhythmias. Diagnosis requires biochemical testing combined with adrenal imaging. Preoperative medical stabilization with an alpha-adrenergic blocker is standard to reduce intraoperative cardiovascular complications. Surgical adrenalectomy is the definitive treatment but carries significant anesthetic and surgical risk. The table below summarizes key decision points for clinicians.

Pathophysiology and Clinical Presentation

Pheochromocytoma originates from chromaffin cells of the adrenal medulla. These tumors secrete catecholamines (norepinephrine, epinephrine, and dopamine) in an uncontrolled manner, often episodically. The clinical signs are directly related to the cardiovascular effects of these hormones. Episodic release causes paroxysmal hypertension, tachycardia, and arrhythmias. Sustained secretion leads to chronic hypertension and myocardial damage. The tumor can also invade local vessels, most commonly the caudal vena cava, leading to venous obstruction or tumor embolization.

Common clinical signs include episodic weakness, collapse, panting, restlessness, and behavioral changes. Physical examination may reveal hypertension (systolic blood pressure greater than 180 mmHg), tachycardia, and a palpable abdominal mass. Some dogs present with acute blindness due to hypertensive retinopathy or retinal detachment. Others may show signs of congestive heart failure or pulmonary edema. A high index of suspicion is needed because many dogs have intermittent signs or are asymptomatic until a crisis occurs.

A retrospective study titled "Pheochromocytoma in 50 dogs" published in the Journal of Veterinary Internal Medicine in 1994 described the clinical features of this condition. Another study titled "Pheochromocytoma in dogs: 61 cases (1984-1995)" published in the same journal in 1997 provided additional characterization of the clinical presentation and outcomes. These studies highlight the variability in clinical signs and the importance of considering pheochromocytoma in dogs with episodic cardiovascular abnormalities.

Signalment and Breed Predisposition

Pheochromocytoma is most commonly diagnosed in middle-aged to older dogs, with a median age at diagnosis of approximately 10-12 years. No strong breed predisposition has been consistently documented, but some reports suggest a higher prevalence in large breed dogs. Both sexes appear equally affected. Clinicians should maintain a high index of suspicion in any older dog presenting with episodic cardiovascular signs, regardless of breed.

Pathophysiology of Catecholamine Excess

The pathophysiology of pheochromocytoma involves unregulated secretion of catecholamines from tumor cells. Norepinephrine is the predominant catecholamine secreted in most canine pheochromocytomas, leading to alpha-adrenergic receptor stimulation and vasoconstriction. Epinephrine secretion, when present, causes beta-adrenergic effects including tachycardia and increased myocardial contractility. The episodic nature of secretion leads to paroxysmal clinical signs, while sustained secretion causes chronic cardiovascular changes including hypertension, myocardial hypertrophy, and arrhythmias.

Clinical Signs and Physical Examination Findings

The clinical presentation of pheochromocytoma is highly variable. Common presenting complaints include episodic weakness, collapse, panting, restlessness, and behavioral changes. Owners may report episodes that last minutes to hours, often triggered by excitement, exercise, or abdominal palpation. Physical examination findings may include hypertension, tachycardia, arrhythmias, and a palpable abdominal mass. Some dogs present with acute blindness due to hypertensive retinopathy or retinal detachment. Others may show signs of congestive heart failure or pulmonary edema. A high index of suspicion is needed because many dogs have intermittent signs or are asymptomatic until a crisis occurs.

Differential Diagnoses for Episodic Collapse

Episodic collapse in dogs has many potential causes. Differential diagnoses include cardiac arrhythmias (e.g., sick sinus syndrome, atrial fibrillation), syncope due to structural heart disease, seizure disorders, narcolepsy, myasthenia gravis, and metabolic disorders such as hypoglycemia or hypoadrenocorticism. The presence of hypertension and tachycardia during episodes should raise suspicion for pheochromocytoma. A thorough history, physical examination, and diagnostic workup are essential to differentiate these conditions.

Diagnostic Workup

The diagnostic approach for pheochromocytoma involves biochemical confirmation followed by imaging for tumor localization and staging. A systematic approach reduces the risk of misdiagnosis and ensures appropriate surgical planning.

Biochemical Testing

Plasma free metanephrines (normetanephrine and metanephrine) are the preferred screening test. These metabolites are more stable and have a longer half-life than catecholamines, making them less affected by stress or episodic secretion. A study titled "Detection of catecholamines and metanephrines by radio-immunoassay in canine plasma" published in the Veterinary Journal in 2010 described a radioimmunoassay method for measuring these analytes. Elevated plasma normetanephrine is highly suggestive of pheochromocytoma.

Urinary vanillylmandelic acid (VMA) to creatinine ratio is an alternative noninvasive test. A study titled "Urinary vanillylmandelic acid:creatinine ratio in dogs with pheochromocytoma" published in Domestic Animal Endocrinology in 2021 evaluated this test. Urine collection is noninvasive, but results can be affected by diet and stress. Both tests should be interpreted in the context of the clinical picture.

Imaging

Abdominal ultrasound is often the first imaging modality. Pheochromocytomas typically appear as a heterogeneous adrenal mass, often with areas of necrosis or hemorrhage. Doppler ultrasound can assess vascular invasion. Computed tomography (CT) provides better detail of tumor size, local invasion, and metastasis. CT is essential for surgical planning. Magnetic resonance imaging (MRI) is an alternative if CT is unavailable.

Differential Diagnoses

Other adrenal masses include adrenocortical adenoma, adrenocortical carcinoma, and metastatic disease. Functional adrenocortical tumors (Cushing's syndrome) can be differentiated by ACTH stimulation test or low-dose dexamethasone suppression test. A case report titled "Favorable outcome of pheochromocytoma in a dog with atypical Cushing's syndrome and diabetes mellitus following medical treatment: A case report" published in BMC Veterinary Research in 2020 highlighted the possibility of concurrent endocrine disorders. This case emphasizes the need for thorough endocrine evaluation in dogs with adrenal masses.

Diagnostic Algorithm

A stepwise diagnostic approach is recommended. First, obtain a thorough history and perform a complete physical examination with blood pressure measurement. If clinical suspicion is high, measure plasma free metanephrines or urinary VMA:creatinine ratio. If biochemical testing is consistent with pheochromocytoma, perform abdominal imaging (ultrasound or CT) to localize the tumor and assess for vascular invasion and metastasis. If an adrenal mass is identified but biochemical testing is equivocal, consider repeat testing or referral to a specialist. Fine-needle aspiration of the adrenal mass is generally avoided due to the risk of hemorrhage and catecholamine release.

Limitations of Diagnostic Testing

Biochemical testing for pheochromocytoma has limitations. False positives can occur due to stress, other tumors, or certain medications. Plasma metanephrines may be normal in dogs with small tumors or intermittent secretion. Urinary VMA:creatinine ratio can be affected by diet and stress. Imaging findings are not specific for pheochromocytoma, and other adrenal masses can appear similar. A definitive diagnosis requires histopathologic examination of the tumor after surgical removal.

Preoperative Medical Stabilization

Preoperative management with phenoxybenzamine is standard. This nonselective alpha-adrenergic blocker reduces the effects of catecholamines on vascular smooth muscle, lowering blood pressure and decreasing the risk of intraoperative hypertensive crisis. A study titled "Retrospective evaluation of the influence of phenoxybenzamine pretreatment on intraoperative cardiovascular variables in dogs with pheochromocytoma" published in The Canadian Veterinary Journal in 2024 evaluated the impact of this pretreatment. The study found that phenoxybenzamine pretreatment was associated with improved intraoperative cardiovascular stability.

Phenoxybenzamine is typically started 7-14 days before surgery. The dose is titrated based on blood pressure response. Common side effects include hypotension, bradycardia, and nasal congestion. Beta-blockers (e.g., propranolol) are added only after adequate alpha-blockade to prevent unopposed alpha-mediated vasoconstriction. Beta-blockers control tachycardia and arrhythmias.

Monitoring During Stabilization

Blood pressure should be monitored at least twice daily during the stabilization period. Heart rate and rhythm should be assessed regularly. Owners should be educated about signs of hypotension (weakness, lethargy, collapse) and instructed to seek veterinary care if these occur. The goal of stabilization is to achieve normotension and reduce the frequency and severity of clinical episodes.

Beta-Blocker Considerations

Beta-blockers should never be initiated before adequate alpha-blockade is established. If beta-blockers are given first, unopposed alpha-receptor stimulation can lead to severe hypertension and hypertensive crisis. Once alpha-blockade is established, beta-blockers can be added to control tachycardia and arrhythmias. The choice of beta-blocker (e.g., propranolol, atenolol) depends on the individual patient and clinician preference.

Duration of Preoperative Stabilization

The optimal duration of preoperative stabilization is not well established, but most clinicians recommend 7-14 days of phenoxybenzamine therapy before surgery. This allows adequate time for blood pressure control and reduction of catecholamine effects. Some dogs may require longer stabilization if blood pressure is not well controlled. The decision to proceed with surgery should be based on clinical response and blood pressure measurements.

Alternative Alpha-Blockers

Phenoxybenzamine is the most commonly used alpha-blocker for preoperative stabilization of pheochromocytoma in dogs. However, other alpha-blockers such as prazosin or doxazosin may be used if phenoxybenzamine is not available or is poorly tolerated. These agents have a shorter duration of action and may require more frequent dosing. The choice of alpha-blocker should be based on clinician experience and patient response.

Surgical Management

Adrenalectomy is the definitive treatment for nonmetastatic pheochromocytoma. The surgical approach can be open (laparotomy) or minimally invasive (laparoscopic). The choice depends on tumor size, location, and surgeon experience. Laparoscopic adrenalectomy is associated with less postoperative pain and faster recovery, but requires specialized equipment and expertise.

A study titled "Pheochromocytoma in Dogs Undergoing Adrenalectomy" published in Veterinary Pathology in 2019 examined the histopathologic features of these tumors in dogs that underwent surgical resection. This study provides important information about tumor characteristics that influence surgical planning and prognosis.

Anesthetic Considerations

Intraoperative management is critical. Anesthesia must be tailored to avoid catecholamine release. Drugs that stimulate the sympathetic nervous system (e.g., ketamine, atropine) are avoided. Continuous blood pressure monitoring is essential. Hypertensive crises are treated with short-acting vasodilators like sodium nitroprusside or phentolamine. Hypotension after tumor removal is managed with intravenous fluids and vasopressors.

Surgical Technique

The surgeon must carefully dissect the adrenal gland and its blood supply. The adrenal vein is ligated early to reduce catecholamine release during manipulation. The tumor should be handled gently to avoid compression and catecholamine release. Complete resection with clean margins is the goal. If vascular invasion is present, partial venacaval resection may be necessary.

Laparoscopic Versus Open Adrenalectomy

The choice between laparoscopic and open adrenalectomy depends on several factors. Laparoscopic adrenalectomy is associated with less postoperative pain, shorter hospital stay, and faster recovery. However, it requires specialized equipment and surgical expertise. Open adrenalectomy may be preferred for large tumors, tumors with vascular invasion, or when laparoscopic equipment is not available. The surgeon should choose the approach that provides the best chance of complete resection with minimal complications.

Intraoperative Hypertensive Crisis Management

Intraoperative hypertensive crisis is a serious complication that requires immediate intervention. Short-acting vasodilators such as sodium nitroprusside or phentolamine are used to lower blood pressure. Beta-blockers such as esmolol can be used to control tachycardia. The anesthesia team must be prepared to manage these crises and communicate closely with the surgeon. If hypertensive crisis occurs, the surgeon should temporarily stop manipulating the tumor until blood pressure is controlled.

Postoperative Hypotension Management

Postoperative hypotension is common after adrenalectomy for pheochromocytoma due to sudden withdrawal of catecholamines. Intravenous fluids (crystalloids or colloids) are administered to maintain blood pressure. Vasopressors such as dopamine or norepinephrine may be needed if hypotension persists. Blood pressure should be monitored continuously in the immediate postoperative period. Most dogs require fluid support for 24-48 hours after surgery.

Postoperative Care and Prognosis

Postoperative care focuses on monitoring for hypotension, arrhythmias, and hypoglycemia. Hypotension is common due to sudden withdrawal of catecholamines. Intravenous fluids and vasopressors may be needed. Arrhythmias are managed with beta-blockers or antiarrhythmic drugs. Hypoglycemia can occur due to rebound insulin secretion.

The prognosis for dogs with complete surgical resection is good. A study titled "Pheochromocytoma in dogs: 61 cases (1984-1995)" published in the Journal of Veterinary Internal Medicine in 1997 reported a median survival time of 1.5 years for dogs that underwent adrenalectomy. Dogs with metastatic disease have a poorer prognosis. Regular monitoring with blood pressure measurement and imaging is recommended.

Long-term Monitoring

Dogs that have undergone successful adrenalectomy should have blood pressure checked every 3-6 months. Abdominal ultrasound or CT should be performed annually to monitor for recurrence or metastasis. Owners should be educated about signs of recurrence, including episodic weakness, collapse, or hypertension.

Prognostic Factors

Several factors influence prognosis in dogs with pheochromocytoma. Complete surgical resection with clean margins is associated with the best prognosis. The presence of vascular invasion or metastasis is associated with a poorer prognosis. Tumor size and histologic features may also influence prognosis. Dogs with metastatic disease may survive 6-12 months with palliative medical management.

Palliative Medical Management

For dogs that are not surgical candidates due to metastasis or comorbidities, palliative medical management is an option. Phenoxybenzamine and beta-blockers can control clinical signs and improve quality of life. Regular monitoring for tumor progression and clinical signs is recommended. The prognosis for dogs managed medically is guarded, with median survival times of 6-12 months reported in some studies.

Common Failure Patterns

Several factors can lead to poor outcomes in dogs with pheochromocytoma. Incomplete preoperative stabilization increases the risk of intraoperative hypertensive crisis. Inadequate imaging may miss vascular invasion or metastasis, leading to incomplete resection. Anesthetic mismanagement can trigger catecholamine release and cardiovascular collapse. Postoperative hypotension and arrhythmias require prompt recognition and treatment.

Failure Pattern 1: Inadequate Preoperative Stabilization

Dogs that are not adequately stabilized with phenoxybenzamine before surgery are at high risk for intraoperative hypertensive crisis. This can lead to severe hypertension, arrhythmias, myocardial damage, and death. The stabilization period should be at least 7-14 days, and blood pressure should be monitored closely.

Failure Pattern 2: Incomplete Imaging

Imaging that does not adequately assess for vascular invasion or metastasis can lead to incomplete surgical resection. CT with contrast is the preferred imaging modality for surgical planning. The surgeon should review the images carefully before surgery.

Failure Pattern 3: Anesthetic Mismanagement

Anesthetic drugs that stimulate the sympathetic nervous system can trigger catecholamine release and hypertensive crisis. The anesthesia team must be experienced with pheochromocytoma cases and have a plan for managing hypertensive crises.

Failure Pattern 4: Postoperative Hypotension

Sudden withdrawal of catecholamines after tumor removal can cause profound hypotension. Intravenous fluids and vasopressors may be needed for 24-48 hours after surgery. Blood pressure should be monitored continuously in the immediate postoperative period.

Failure Pattern 5: Incomplete Tumor Resection

Incomplete tumor resection due to vascular invasion or local invasion can lead to recurrence. The surgeon should carefully assess the tumor and surrounding tissues during surgery. If complete resection is not possible, palliative medical management should be considered.

Failure Pattern 6: Delayed Recognition of Metastasis

Metastatic disease may not be apparent at the time of diagnosis. Regular monitoring with imaging is essential to detect metastasis early. Dogs with metastatic disease may benefit from palliative medical management.

Records and Measurements

Accurate record-keeping is essential for managing dogs with pheochromocytoma. The following records should be maintained:

Blood Pressure Monitoring Protocol

Blood pressure should be measured using a consistent technique. Indirect blood pressure measurement using Doppler or oscillometric methods is acceptable. The dog should be in a quiet environment and allowed to acclimate before measurement. Multiple readings should be taken and averaged. Systolic blood pressure greater than 180 mmHg is considered hypertensive and requires intervention.

Clinical Episode Documentation

Owners should be instructed to document clinical episodes in a log. The log should include the date, time, duration, severity, and any triggering factors. This information helps assess response to treatment and identify patterns. Episodes that are increasing in frequency or severity may indicate tumor progression or inadequate medical management.

Professional Escalation Criteria

Veterinary clinicians should seek specialist consultation or referral in the following situations:

• Suspected pheochromocytoma in a dog with uncontrolled hypertension or recurrent collapse
• Adrenal mass with evidence of vascular invasion on imaging
• Need for advanced imaging (CT or MRI) for surgical planning
• Intraoperative hypertensive crisis that is difficult to control
• Postoperative hypotension or arrhythmias that do not respond to initial treatment
• Recurrent clinical signs after adrenalectomy
• Metastatic disease requiring palliative management

Referral to a veterinary internal medicine specialist or a veterinary surgeon with experience in adrenal surgery is recommended for complex cases. The American College of Veterinary Internal Medicine (ACVIM) provides a directory of board-certified specialists (www.acvim.org). The American Animal Hospital Association (AAHA) also provides resources for finding accredited veterinary practices (www.aaha.org/resources).

When to Refer to a Specialist

Referral to a specialist should be considered when the diagnosis is uncertain, when advanced imaging is needed, or when surgical management is planned. Specialists in veterinary internal medicine can assist with biochemical testing and medical management. Veterinary surgeons with experience in adrenal surgery can perform adrenalectomy with lower complication rates. Anesthesia specialists can help manage the complex anesthetic considerations in these cases.

Emergency Referral Criteria

Emergency referral is indicated for dogs with uncontrolled hypertensive crisis, severe arrhythmias, or cardiovascular collapse. These dogs require intensive monitoring and treatment that may not be available in general practice. Emergency referral should also be considered for dogs with suspected tumor rupture or hemorrhage.

Welfare and Safety Context

Pheochromocytoma is a serious condition that can cause significant morbidity and mortality if not recognized and managed appropriately. The World Organisation for Animal Health (WOAH) provides guidelines for animal health and welfare that apply to the management of dogs with endocrine tumors (www.woah.org/en/what-we-do/animal-health-and-welfare). Veterinary clinicians have a responsibility to provide timely diagnosis, appropriate medical stabilization, and safe surgical management.

Owners should be counseled about the risks and benefits of treatment. The decision to pursue surgery should be based on the dog's overall health, tumor characteristics, and owner's ability to provide postoperative care. Palliative medical management is an option for dogs that are not surgical candidates.

Owner Communication and Informed Consent

Owners should be provided with clear information about the diagnosis, treatment options, and prognosis. The risks and benefits of surgery should be discussed, including the potential for intraoperative complications and postoperative monitoring requirements. Owners should also be informed about the possibility of recurrence and the need for long-term monitoring. Written informed consent should be obtained before any diagnostic or therapeutic procedures.

Quality of Life Assessment

Quality of life should be assessed regularly in dogs with pheochromocytoma. Factors to consider include the frequency and severity of clinical episodes, the dog's activity level and appetite, and the owner's ability to provide care. If quality of life is poor despite medical management, euthanasia may be considered. The decision to euthanize should be made in consultation with the owner and based on the dog's overall condition.

Practical Decision Framework for Intraoperative Blood Pressure Management in Canine Pheochromocytoma

Intraoperative blood pressure instability represents the most critical management challenge during adrenalectomy for pheochromocytoma. The unpredictable release of catecholamines during tumor manipulation can precipitate hypertensive crises, while sudden catecholamine withdrawal after tumor removal often causes profound hypotension. A structured decision framework helps the surgical and anesthesia teams respond rapidly and appropriately to these hemodynamic changes. This section provides a practical algorithm for intraoperative blood pressure management, including specific intervention thresholds, drug selection criteria, and communication protocols.

Preoperative Risk Stratification for Intraoperative Hemodynamic Instability

Before entering the operating room, the clinician should assign each patient a risk category based on preoperative findings. This stratification guides preparation and resource allocation. Low-risk patients include those with adequate alpha-blockade (systolic blood pressure consistently below 160 mmHg on phenoxybenzamine), no evidence of vascular invasion on imaging, and no history of refractory hypertensive episodes. Moderate-risk patients have systolic blood pressure 160-180 mmHg despite phenoxybenzamine, mild vascular invasion, or intermittent breakthrough episodes. High-risk patients have systolic blood pressure above 180 mmHg despite maximal alpha-blockade, extensive vascular invasion, large tumors (greater than 5 cm), or concurrent cardiac disease.

The risk category determines the level of monitoring and the specific drugs that should be immediately available. For low-risk cases, standard intraoperative monitoring with a short-acting vasodilator on standby may suffice. For moderate-risk cases, an arterial catheter for continuous blood pressure monitoring and two vasoactive drugs should be prepared. For high-risk cases, the anesthesia team should have three or more vasoactive agents drawn up and labeled, and a second veterinarian should be present to manage hemodynamics while the surgeon focuses on the procedure.

Intraoperative Blood Pressure Monitoring Protocol

Continuous direct arterial blood pressure monitoring is strongly recommended for all pheochromocytoma adrenalectomies. Indirect oscillometric or Doppler methods provide intermittent readings that may miss rapid fluctuations during tumor manipulation. The arterial catheter should be placed before surgical incision and calibrated to zero at the level of the heart. Blood pressure readings should be recorded every 1-2 minutes during tumor dissection and every 5 minutes during other phases of surgery.

The target blood pressure range during surgery is a mean arterial pressure (MAP) of 60-100 mmHg. Systolic blood pressure should remain below 180 mmHg. If systolic pressure exceeds 200 mmHg or MAP exceeds 120 mmHg for more than 30 seconds, intervention is indicated. If systolic pressure falls below 80 mmHg or MAP falls below 60 mmHg, intervention is also indicated. These thresholds are based on clinical experience and published recommendations from the Merck Veterinary Manual (www.merckvetmanual.com).

Hypertensive Crisis Management Algorithm

When systolic blood pressure exceeds 200 mmHg or MAP exceeds 120 mmHg, the following stepwise approach should be implemented. First, the surgeon should immediately stop all tumor manipulation and apply gentle pressure to the surgical site if bleeding is not present. The anesthesia team should verify that the patient is adequately anesthetized and that no sympathetic stimulation is occurring from light anesthesia.

Second, administer a short-acting vasodilator. Sodium nitroprusside is the preferred first-line agent because of its rapid onset (seconds) and short duration of action (1-2 minutes). The initial dose is 0.5-1.0 mcg/kg/min as a constant rate infusion, titrated to effect. Phentolamine, a short-acting alpha-blocker, is an alternative at 0.02-0.1 mg/kg intravenously, repeated every 5 minutes as needed. The study titled "Retrospective evaluation of the influence of phenoxybenzamine pretreatment on intraoperative cardiovascular variables in dogs with pheochromocytoma" published in The Canadian Veterinary Journal in 2024 (https://pubmed.ncbi.nlm.nih.gov/39649740) provides evidence that preoperative phenoxybenzamine reduces the severity of intraoperative hypertensive episodes, but breakthrough crises still occur and require prompt treatment.

Third, if tachycardia (heart rate greater than 160 beats per minute) accompanies hypertension, add a short-acting beta-blocker. Esmolol is preferred because of its rapid onset and short half-life. The initial dose is 0.5 mg/kg intravenously over 1 minute, followed by a constant rate infusion of 50-200 mcg/kg/min. Beta-blockers should never be administered before alpha-blockade is established, as this can worsen hypertension due to unopposed alpha-receptor stimulation.

Fourth, if blood pressure does not respond to the above measures within 2-3 minutes, consider deepening anesthesia with an inhalant agent such as sevoflurane or isoflurane. Propofol can be used as a bolus of 0.5-1.0 mg/kg intravenously if the patient is not already deeply anesthetized. The surgeon should consider temporarily packing the surgical site and waiting 5-10 minutes before resuming dissection.

Hypotension Management Algorithm

After tumor removal, sudden withdrawal of catecholamines often causes hypotension. When systolic blood pressure falls below 80 mmHg or MAP falls below 60 mmHg, the following steps should be taken. First, reduce or discontinue any vasodilators that were being administered. Second, administer a bolus of intravenous crystalloid fluids (10-20 mL/kg over 10-15 minutes). If hypotension persists, consider colloid administration (5-10 mL/kg of hetastarch or similar product).

Third, if fluid resuscitation alone is insufficient, start a vasopressor infusion. Dopamine is the first-line agent at 5-15 mcg/kg/min as a constant rate infusion. Norepinephrine is an alternative at 0.05-0.3 mcg/kg/min. Vasopressin can be used as a second-line agent at 0.5-2.0 mU/kg/min. The choice of vasopressor depends on the patient's heart rate and rhythm. Dopamine is preferred if bradycardia is present, while norepinephrine is preferred if tachycardia is a concern.

Fourth, if hypotension persists despite fluids and vasopressors, consider the possibility of hypovolemia from hemorrhage, hypoglycemia, or hypocalcemia. Check packed cell volume, blood glucose, and ionized calcium. Administer blood products if anemia is present. Correct any metabolic abnormalities.

Drug Preparation and Labeling Protocol

Before surgery begins, the anesthesia team should prepare and label the following drugs: sodium nitroprusside (or phentolamine), esmolol, dopamine (or norepinephrine), and atropine. Each drug should be drawn up in a separate syringe and clearly labeled with the drug name, concentration, and dose. The syringes should be placed in a designated location on the anesthesia machine where they are immediately accessible. A drug calculation sheet should be completed before surgery, with doses calculated based on the patient's body weight.

The study titled "Pheochromocytoma in Dogs Undergoing Adrenalectomy" published in Veterinary Pathology in 2019 (https://pubmed.ncbi.nlm.nih.gov/30595108) emphasizes that careful surgical technique and preoperative planning reduce but do not eliminate the need for intraoperative vasoactive drug administration. Having drugs prepared in advance reduces response time during a crisis.

Communication Protocol Between Surgeon and Anesthetist

Effective communication is essential during pheochromocytoma adrenalectomy. Before surgery, the surgeon and anesthetist should review the patient's risk category, the planned surgical approach, and the specific steps during which tumor manipulation will occur. The surgeon should announce when tumor dissection is about to begin, when the adrenal vein is being ligated, and when the tumor is being removed. The anesthetist should announce any significant changes in blood pressure, heart rate, or rhythm.

A standardized communication tool such as the "SBAR" (Situation, Background, Assessment, Recommendation) format can be used during crises. For example, the anesthetist might say: "Situation: hypertensive crisis. Background: systolic blood pressure 220 mmHg during tumor manipulation. Assessment: patient is at risk for myocardial damage. Recommendation: stop tumor manipulation and administer sodium nitroprusside." This structured communication reduces errors and ensures that both team members are working from the same information.

Postoperative Blood Pressure Management

After the tumor is removed and the surgical incision is closed, blood pressure should be monitored continuously for at least 4-6 hours in the recovery area. Hypotension is the most common postoperative complication, occurring in 30-50% of cases. The study titled "Pheochromocytoma in dogs: 61 cases (1984-1995)" published in the Journal of Veterinary Internal Medicine in 1997 (https://pubmed.ncbi.nlm.nih.gov/9348493) reported that postoperative hypotension was a significant cause of morbidity in dogs undergoing adrenalectomy.

If hypotension persists beyond 4-6 hours despite fluid therapy and vasopressors, consider the possibility of ongoing hemorrhage, sepsis, or hypoadrenocorticism. Check a complete blood count, serum biochemistry, and cortisol level. If hypoadrenocorticism is confirmed, administer glucocorticoid supplementation. If hemorrhage is suspected, perform an abdominal ultrasound or CT to identify the source.

Common Failure Patterns in Intraoperative Blood Pressure Management

Several recurring problems can undermine intraoperative blood pressure control. The first failure pattern is delayed recognition of hypertensive crisis. If the anesthesia team relies on intermittent blood pressure measurements instead of continuous arterial monitoring, they may miss rapid spikes in pressure during tumor manipulation. This delay can lead to prolonged hypertension and increased risk of myocardial damage or cerebral hemorrhage.

The second failure pattern is inadequate drug dosing. Some clinicians underdose vasodilators due to fear of causing hypotension. However, hypertensive crises require aggressive treatment to prevent end-organ damage. The doses listed above are starting points and should be titrated to effect. If blood pressure does not respond to the initial dose, increase the dose or add a second agent.

The third failure pattern is failure to communicate between surgeon and anesthetist. If the surgeon does not announce when tumor manipulation is occurring, the anesthetist may not be prepared for a hypertensive crisis. Conversely, if the anesthetist does not announce a hypertensive crisis, the surgeon may continue manipulating the tumor, worsening the situation. Regular communication throughout the procedure is essential.

The fourth failure pattern is premature discontinuation of vasopressors after surgery. Some dogs require vasopressor support for 24-48 hours after adrenalectomy. If vasopressors are discontinued too early, hypotension can recur. The vasopressor infusion should be weaned gradually based on blood pressure response, not discontinued abruptly.

Records and Measurements for Intraoperative Blood Pressure Management

The anesthesia record should include the following information: baseline blood pressure before induction, blood pressure readings every 1-2 minutes during tumor dissection and every 5 minutes during other phases, all vasoactive drug administrations with dose, route, and time, any episodes of hypertension or hypotension with duration and treatment, and the final blood pressure at the end of surgery. This record is essential for postoperative management and for identifying patterns that may inform future cases.

A standardized intraoperative blood pressure log can be created using the following format:

This log allows the team to track trends and assess the effectiveness of interventions in real time.

Professional Escalation Criteria for Intraoperative Blood Pressure Crises

If hypertensive crisis does not respond to the above measures within 5 minutes, or if the patient develops arrhythmias, seizures, or signs of myocardial ischemia, the surgeon should consider aborting the procedure and closing the incision. The patient should be stabilized in the intensive care unit and referred to a veterinary teaching hospital or specialty center with 24-hour critical care capabilities. The American College of Veterinary Internal Medicine (www.acvim.org) provides a directory of board-certified specialists who can manage complex pheochromocytoma cases.

If postoperative hypotension does not respond to fluid therapy and vasopressors within 6 hours, or if the patient develops oliguria, altered mental status, or signs of shock, the patient should be transferred to a critical care facility. The American Animal Hospital Association (www.aaha.org/resources) provides resources for finding accredited emergency and critical care facilities.

Welfare and Safety Context for Intraoperative Blood Pressure Management

The World Organisation for Animal Health (www.woah.org/en/what-we-do/animal-health-and-welfare) emphasizes that surgical procedures should be performed with the goal of minimizing pain, distress, and complications. Intraoperative hypertensive crises and hypotension are significant welfare concerns because they can cause pain, anxiety, and end-organ damage. The veterinary team has a responsibility to prepare for these complications and respond promptly when they occur.

Owners should be informed before surgery that intraoperative blood pressure instability is a known risk of pheochromocytoma adrenalectomy. They should understand that the surgical team will take all reasonable precautions, but that complications can still occur. Written informed consent should include a discussion of the specific risks of hypertensive crisis, arrhythmias, hemorrhage, and postoperative hypotension. The owner should also be informed that the dog may require intensive postoperative monitoring and vasopressor support for 24-48 hours after surgery.

Frequently Asked Questions

What is the most reliable diagnostic test for pheochromocytoma in dogs?

Plasma free metanephrines are the preferred screening test. They are more stable than catecholamines and less affected by stress. Elevated normetanephrine is highly suggestive of pheochromocytoma. Urinary vanillylmandelic acid to creatinine ratio is an alternative noninvasive test.

How long should phenoxybenzamine be given before surgery?

Phenoxybenzamine is typically started 7-14 days before planned adrenalectomy. The dose is titrated based on blood pressure response. Adequate alpha-blockade reduces the risk of intraoperative hypertensive crisis.

Can pheochromocytoma be managed without surgery?

Yes, medical management with phenoxybenzamine and beta-blockers can control clinical signs in dogs that are not surgical candidates due to metastasis or comorbidities. However, prognosis is guarded, and tumor progression is expected.

What are the risks of adrenalectomy for pheochromocytoma?

The main risks include intraoperative hypertensive crisis, arrhythmias, hemorrhage, and postoperative hypotension. Anesthetic management must be tailored to avoid catecholamine release. Experienced surgical and anesthesia teams are essential.

How is pheochromocytoma differentiated from other adrenal tumors?

Biochemical testing (plasma metanephrines or urinary VMA) confirms catecholamine secretion. Imaging (CT or ultrasound) can suggest pheochromocytoma based on heterogeneous appearance and vascular invasion. Fine-needle aspiration is avoided due to risk of hemorrhage and catecholamine release.

What is the prognosis for dogs with pheochromocytoma?

The prognosis is good for dogs with complete surgical resection. Median survival time is approximately 1.5 years. Dogs with metastatic disease have a poorer prognosis. Regular monitoring is recommended.

Can pheochromocytoma recur after surgery?

Recurrence is possible if the tumor is incompletely resected or if metastatic disease is present. Regular follow-up with blood pressure measurement and imaging is recommended.

What should I do if a dog with pheochromocytoma has a hypertensive crisis?

Immediate veterinary intervention is required. Short-acting vasodilators like sodium nitroprusside or phentolamine are used to lower blood pressure. Beta-blockers may be added for tachycardia. The dog should be hospitalized for monitoring.

Related Veterinary Guides

• Dog
• Arthritis In Dogs Symptoms And Diagnosis
• Dog Pregnancy Symptoms
• Dog Shedding Management
• How To Skin A Dog

References and Further Reading

• www.merckvetmanual.com
• www.aaha.org
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Pheochromocytoma in Dogs Undergoing Adrenalectomy.. Veterinary pathology, 2019.
• Pheochromocytoma in dogs and cats.. The Veterinary clinics of North America. Small animal practice, 1997.
• Pheochromocytoma in 50 dogs.. Journal of veterinary internal medicine, 1994.
• Urinary vanillylmandelic acid:creatinine ratio in dogs with pheochromocytoma.. Domestic animal endocrinology, 2021.
• Retrospective evaluation of the influence of phenoxybenzamine pretreatment on intraoperative cardiovascular variables in dogs with pheochromocytoma.. The Canadian veterinary journal = La revue veterinaire canadienne, 2024.
• Pheochromocytoma in dogs: 61 cases (1984-1995).. Journal of veterinary internal medicine, 1997.
• Detection of catecholamines and metanephrines by radio-immunoassay in canine plasma. Veterinary Journal, 2010.
• Favorable outcome of pheochromocytoma in a dog with atypical Cushing's syndrome and diabetes mellitus following medical treatment: A case report. BMC Veterinary Research, 2020.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.